MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation Operating Cash Flow 2011-2025 | HSKA
Annual Operating Cash Flow Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.8 M | 6.25 M | -656 K | 3.3 M | 13.3 M | 10.4 M | 5.86 M | 2.12 M | 5.55 M | -1.41 M | -369 K | 4.89 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | -21.8 M | 2.28 M |
Quarterly Operating Cash Flow Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.16 M | - | -18.7 M | -16.6 M | -17.7 M | - | 5.27 M | 7.15 M | 1.34 M | - | -8.1 M | -13.1 M | -4.76 M | - | -3.28 M | -5.36 M | 727 K | - | 6.46 M | 4.5 M | 4.21 M | - | 6.28 M | 4.86 M | 1.93 M | - | 1.88 M | 278 K | -637 K | - | -932 K | -282 K | -1.39 M | - | 3.6 M | 3.16 M | 5.22 M | - | -1.26 M | -1.06 M | 510 K | - | 1.02 M | 2.07 M | -255 K | - | 5.62 M | 3.57 M | -151 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.15 M | -18.7 M | -892 K |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 19.33 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.97 | -1.38 % | $ 226 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 0.23 | -4.4 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.53 | -1.4 % | $ 1.1 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.52 | - | $ 1.93 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.17 | 1.29 % | $ 289 M | Israel |
 |
DexCom
DXCM
|
748 M | $ 67.51 | 0.13 % | $ 26.1 B | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 230.0 | -0.45 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.56 | 0.02 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 26.78 | -0.85 % | $ 810 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 19.47 | -1.32 % | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 101.9 | -0.7 % | $ 4.02 B | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.21 | -6.25 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 226.52 | 0.26 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
-240 M | $ 103.35 | 0.94 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.44 | -1.68 % | $ 583 M | USA |
 |
Illumina
ILMN
|
837 M | $ 135.12 | -0.15 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 203.88 | - | $ 10.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.94 | -3.14 % | $ 2.65 M | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 7.12 | -0.35 % | $ 1.54 B | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 18.74 | 0.46 % | $ 460 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 176.16 | 0.15 % | $ 19.6 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 6.76 | -0.88 % | $ 877 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 254.32 | 0.02 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 182.75 | -0.51 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 688.22 | 0.01 % | $ 56.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
-259 M | $ 1.77 | -5.85 % | $ 449 M | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 66.73 | 0.07 % | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 419.64 | 0.11 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
1.48 B | $ 138.31 | 0.03 % | $ 42 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.7 | 1.9 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
15.3 M | $ 7.4 | 0.27 % | $ 464 M | USA |
 |
NeoGenomics
NEO
|
7.02 M | $ 12.33 | 0.2 % | $ 1.56 B | USA |